Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
暂无分享,去创建一个
K. Matthay | S. Lessnick | E. Sinclair | D. Hawkins | C. Mackall | K. Janeway | R. Gorlick | H. Grier | M. Krailo | R. Womer | D. Barkauskas | C. L. Epling | S. DuBois | P. Barnette | Elizabeth Mcilvaine | Jeremy V. Edwards | K. Vo
[1] J. Healey,et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Desai,et al. Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Reinke,et al. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] U. Dirksen,et al. Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] H. Toledano,et al. Excellent Prognosis in a Subset of Patients with Ewing Sarcoma Identified at Diagnosis by CD56 Using Flow Cytometry , 2011, Clinical Cancer Research.
[6] S. Schuetze,et al. Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study. , 2010, The Lancet. Oncology.
[7] K. Matthay,et al. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow , 2010, Pediatric blood & cancer.
[8] Peter F Ambros,et al. Detecting minimal residual disease in neuroblastoma patients-the present state of the art. , 2005, Cancer letters.
[9] Marino E. Leon,et al. Fine‐needle aspiration of adult small‐round‐cell tumors studied with flow cytometry , 2004, Diagnostic cytopathology.
[10] I. Yaniv,et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors , 2004, Cancer.
[11] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[12] B. Wood,et al. Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. , 2003, American Journal of Clinical Pathology.
[13] E. Ashihara,et al. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation , 2002, British journal of haematology.
[14] O. Delattre,et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] H. Kovar,et al. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT‐PCR: A preliminary evaluation , 1998, International journal of cancer.
[16] N. Cheung,et al. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Sklar,et al. Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] G. Thomas,et al. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.
[19] T. Lion,et al. Detection of tumour cells in peripheral blood and bone marrow from ewing tumour patients by rt‐pcr , 1995, International journal of cancer.
[20] P. Lansdorp,et al. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. , 1994, Blood.
[21] P. Lansdorp,et al. Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.
[22] D. Yee,et al. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[24] W. Winkelmann,et al. Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells , 2005, Journal of Cancer Research and Clinical Oncology.
[25] O. Delattre,et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Kodet,et al. Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR. , 2001, Folia biologica.
[27] L. Ries,et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .